• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival.

作者信息

Rupoli S, Da Lio L, Sisti S, Campanati G, Salvi A, Brianzoni M F, D'Amico S, Cinciripini A, Leoni P

机构信息

Clinic of Hematology, Ospedale Regionale di Torrette, Ancona University, Italy.

出版信息

Ann Hematol. 1994 Apr;68(4):205-12. doi: 10.1007/BF01834368.

DOI:10.1007/BF01834368
PMID:8003563
Abstract

In the present study we analyzed the prognostic significance of several clinical, hematological, and histological parameters recorded at diagnosis in a consecutive series of 72 patients with primary myelofibrosis (PMF). Univariate analysis showed that the most significant indicators of poor survival were the following: age greater than 60, splenomegaly, anemia (hemoglobin > 10 g/dl), leukopenia (WBC < 4 x 10(9)/l or leukocytosis > 14 x 10(9)/l), and any of these histological features: adipose tissue and megakaryocyte reduction, prominent osteoblastic rims along the trabecular bone, presence of peritrabecular megakaryocytes (Mk), absence of normal or giant Mk. The multivariate analysis showed that only the level of hemoglobin and the presence of both normal Mk and fever independently influenced the prognosis. These parameters were used to set up a prognostic scoring system, allowing a feasible prognosis to be made for each patient at the time of diagnosis and identifying those patients in urgent need of new therapeutic approaches.

摘要

相似文献

1
Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival.
Ann Hematol. 1994 Apr;68(4):205-12. doi: 10.1007/BF01834368.
2
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.
Br J Haematol. 1990 May;75(1):4-9. doi: 10.1111/j.1365-2141.1990.tb02609.x.
3
Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic score.
Leuk Lymphoma. 2006 Mar;47(3):441-50. doi: 10.1080/10428190500353315.
4
Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosis.脾肿大对中国原发性骨髓纤维化患者生存的预后影响。
Leuk Res. 2014 Oct;38(10):1207-11. doi: 10.1016/j.leukres.2014.08.006. Epub 2014 Aug 22.
5
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.原发性骨髓纤维化中骨髓纤维化的预后影响。AGIMM 组对 490 例患者的研究。
Am J Hematol. 2016 Sep;91(9):918-22. doi: 10.1002/ajh.24442. Epub 2016 Jul 4.
6
Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution.原发性骨髓纤维化当代预后模型的验证与比较:基于单机构334例患者的分析
Cancer. 2007 May 15;109(10):2083-8. doi: 10.1002/cncr.22630.
7
Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis.原发性骨髓纤维化中循环铁调素、铁蛋白和炎症细胞因子水平的相关性及其预后交互作用。
Am J Hematol. 2013 Apr;88(4):312-6. doi: 10.1002/ajh.23406. Epub 2013 Feb 28.
8
Prognostic factors in myelofibrosis.骨髓纤维化的预后因素。
Pathology. 1982 Oct;14(4):455-61. doi: 10.3109/00313028209092127.
9
Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.骨髓网硬蛋白纤维在原发性骨髓纤维化中的预后意义:评分系统中临床病理参数的评估
Haematologia (Budap). 1994;26(2):75-86.
10
Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.慢性特发性骨髓纤维化:骨髓纤维化及临床参数对122例处于纤维化前期和纤维化期患者无事件生存期的预后影响。一项采用RECPAM方法识别不同预后亚组的回顾性研究。
Ann Hematol. 2003 Oct;82(10):605-11. doi: 10.1007/s00277-003-0719-9. Epub 2003 Aug 28.

引用本文的文献

1
Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib-A Real-Life Longitudinal Study.芦可替尼治疗骨髓纤维化患者的疗效与生存情况——一项真实世界纵向研究
Cancers (Basel). 2023 Oct 20;15(20):5085. doi: 10.3390/cancers15205085.
2
Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular: Project guidelines: Associação Médica Brasileira - 2019.骨髓增殖性肿瘤指南:巴西血液学、血液治疗与细胞治疗协会:项目指南:巴西医学协会 - 2019年
Hematol Transfus Cell Ther. 2019 Jul;41 Suppl 1(Suppl 1):1-73. doi: 10.1016/j.htct.2019.03.001. Epub 2019 May 10.
3

本文引用的文献

1
Agnogenic myeloid metaplasia. A survey of twenty-nine cases and a review of the literature.原发性骨髓化生。29例病例调查及文献综述。
Ann Intern Med. 1962 Sep;57:419-40. doi: 10.7326/0003-4819-57-3-419.
2
Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients.骨髓纤维化。110例患者的临床、血液学及病理学研究。
Am J Med Sci. 1962 Jun;243:697-715. doi: 10.1097/00000441-196206000-00001.
3
Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts.
Usefulness of spleen volume measured by computed tomography for predicting clinical outcome in primary myelofibrosis.
计算机断层扫描测量脾脏体积对预测原发性骨髓纤维化临床结局的价值
Int J Hematol. 2016 Oct;104(4):476-84. doi: 10.1007/s12185-016-2050-y. Epub 2016 Jun 27.
4
Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis.有证据表明,前纤维化骨髓纤维化沿着以原发性骨髓纤维化为特征的临床和生物学连续统排列。
PLoS One. 2012;7(4):e35631. doi: 10.1371/journal.pone.0035631. Epub 2012 Apr 20.
5
Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).原发性血小板增多症、真性红细胞增多症和原发性骨髓纤维化(特发性髓样化生)诊断的临床及病理标准。
Int J Hematol. 2002 Aug;76(2):133-45. doi: 10.1007/BF02982575.
6
Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia.骨髓纤维化:伴有髓外化生的骨髓纤维化的发病机制。法国国家健康与医学研究院骨髓纤维化伴髓外化生研究网络。
Springer Semin Immunopathol. 1999;21(4):491-508. doi: 10.1007/BF00870307.
Blood. 1981 Apr;57(4):781-7.
4
Erythropoiesis in myelofibrosis with myeloid metaplasia: recognition of different classes of patients by erythrokinetics.骨髓纤维化伴髓外化生的红细胞生成:通过红细胞动力学识别不同类型的患者。
Br J Haematol. 1981 Jun;48(2):263-72. doi: 10.1111/j.1365-2141.1981.tb08459.x.
5
Prognostic factors in myelofibrosis.骨髓纤维化的预后因素。
Pathology. 1982 Oct;14(4):455-61. doi: 10.3109/00313028209092127.
6
Osteomyelofibrosis/-sclerosis: a histological and cytogenetic study on core biopsies of the bone marrow.骨髓纤维化/硬化症:一项关于骨髓芯针活检的组织学和细胞遗传学研究
Virchows Arch A Pathol Anat Histol. 1980;389(3):269-86. doi: 10.1007/BF00430655.
7
Anaemia in myelofibrosis: its value in prognosis.骨髓纤维化中的贫血:其在预后中的价值。
Br J Haematol. 1983 May;54(1):79-89. doi: 10.1111/j.1365-2141.1983.tb02069.x.
8
The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.特发性骨髓纤维化综合征。一项侧重于预测生存的预后变量的临床病理综述。
Medicine (Baltimore). 1983 Nov;62(6):353-71.
9
Myelofibrosis and acute megakaryoblastic leukemia in a child: topographic relationship between fibroblasts and megakaryocytes with an alpha-granule defect.一名儿童的骨髓纤维化和急性巨核细胞白血病:成纤维细胞与存在α颗粒缺陷的巨核细胞之间的位置关系
Leuk Res. 1982;6(1):97-110. doi: 10.1016/0145-2126(82)90048-0.
10
Chronic myeloproliferative disorders (CMPD).慢性骨髓增殖性疾病
Pathol Res Pract. 1984 Nov;179(2):131-86. doi: 10.1016/S0344-0338(84)80124-7.